chr4-15936416-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005130.5(FGFBP1):āc.217A>Gā(p.Thr73Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,614,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005130.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGFBP1 | NM_005130.5 | c.217A>G | p.Thr73Ala | missense_variant | 3/3 | ENST00000382333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGFBP1 | ENST00000382333.2 | c.217A>G | p.Thr73Ala | missense_variant | 3/3 | 3 | NM_005130.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152230Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251418Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135876
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461876Hom.: 0 Cov.: 34 AF XY: 0.0000358 AC XY: 26AN XY: 727246
GnomAD4 genome AF: 0.000256 AC: 39AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | The c.217A>G (p.T73A) alteration is located in exon 2 (coding exon 1) of the FGFBP1 gene. This alteration results from a A to G substitution at nucleotide position 217, causing the threonine (T) at amino acid position 73 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at